Severe Resistance to Thyroid Hormone Beta in a Patient with Athyreosis

Thyroid. 2022 Mar;32(3):336-339. doi: 10.1089/thy.2021.0523.

Abstract

We report a patient with congenital hypothyroidism due to athyreosis complicated by a heterozygous thyroid hormone receptor beta (THRβ) gene mutation (R320L), resulting in a severe resistance to thyroid hormone beta phenotype. The proband inherited the mutant allele from his father, presenting a very mild phenotype. While the precise reason for this discrepancy remains unknown, we postulate the possibility of de novo mutation and mosaicism in the father. Correlating thyrotropin (TSH) with free thyroxine (fT4) allowed us to predict the amount of fT4 required to normalize the proband's TSH, which supported the treatment with high dose of levothyroxine.

Keywords: athyreosis; congenital hypothyroidism; levothyroxine treatment; mutation; resistance to thyroid hormone.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Congenital Hypothyroidism* / drug therapy
  • Congenital Hypothyroidism* / genetics
  • Humans
  • Mutation
  • Thyroid Dysgenesis*
  • Thyroid Hormone Receptors beta / genetics
  • Thyroid Hormone Resistance Syndrome* / drug therapy
  • Thyroid Hormone Resistance Syndrome* / genetics
  • Thyroid Hormones / therapeutic use
  • Thyrotropin / therapeutic use
  • Thyroxine / therapeutic use

Substances

  • Thyroid Hormone Receptors beta
  • Thyroid Hormones
  • Thyrotropin
  • Thyroxine